Evaluating the prognostic value of time to metastasis in metachronous mHSPC

(5:54)

What is the prognostic classification of MDS?

(2:15)

The prognostic value of MRD in CLL

(1:19)

The prognostic value of post-therapy LuPSMA-SPECT/CT in mCRPC

(2:39)

The prognostic value of MRD negativity

(3:14)

The prognostic value of peripheral blood MRD status following Elo-KRd in newly diagnosed myeloma

(4:26)

Evaluating the prognostic value of CTCs in patients with myeloma enrolled in the PERSEUS trial

(3:19)

The prognostic value of self-reported fatigue on overall survival in patients with MDS

(1:6)

Pope Francis’ Health Update: Slight Improvement, But Prognosis Still Guarded

(2:53)

Pronostic PMU Quinté Flash à Vincennes, R1C8 du 28 février 2025

(3:51)

CBSE Junior Assistant 2025 | GA - School Education \u0026 Administration | Introduction By Sheetal Ma’am

(48:21)

What is HRMM (High-Risk Multiple Myeloma)? #myeloma

(5:59)

AL amyloidosis and a critical, early diagnosis

(6:47)

Organ Involvement in AL amyloidosis

(4:33)

Soft Tissue Sarcoma | Dr. Talebi discusses \

(20:31)

Brachial Plexus Pre and Postganglionic Injury

(6:19)

Ways to express prognosis - the basics

(3:37)

Acute myeloblastic leukemia - How do I manage in 2022? by Dr. Naval Daver, USA

(1:49:)

Progress in the treatment of TP53 mutated AML

(8:14)

Defining ALL risk factors: the prognostic index

(2:32)

The prognostic value of structural heterogeneity of chromosome 1q in multiple myeloma

(1:53)

The prognostic value of patient-reported outcomes in MDS

(1:30)

Assessing the prognostic value of NGS-based MRD in adults with ALL undergoing SCT

(2:41)

The prognostic impact of TP53 mutation in MPNs

(46)

Dr. Deek on the Prognostic Significance of Immune Cell Infiltration in MIBC

(4:31)

What is the prognostic value of STE?

(2:9)

The prognostic impact of TP53 and IgHV status in the era of targeted therapies in CLL

(2:2)

The Prognostic Value of Molecular Testing

(2:53)

ctDNA may have a prognostic role in stage III colon cancer treated with celecoxib

(5:45)

Evaluating the prognostic value of PSMA PET/CT in mCRPC

(10:1econd)